以蛋白质为基础的口服补水溶液,用于患有结节瘤的患者:一项随机,双盲交叉研究
Charlotte Lock Rud1, Mark Krogh Hvistendahl2, Bente Langdahl3
1Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.
Clinical nutrition (Edinburgh, Scotland)
|June 8, 2024
概括
用乳清蛋白分离剂的口服补水溶液 (ORS) 改善了结肠静脉瘤患者的吸收标记,尽管结肠静脉瘤输出保持不变. 这些基于蛋白质的ORS是安全的,耐受性很好,这表明个性化治疗方法.
科学领域:
- 胃肠病学 胃肠病学
- 临床营养学 临床营养学
- 生物化学 生物化学
背景情况:
- 患有骨髓切除术的患者面临脱水和耗尽的风险.
- 口服补水溶液 (ORS) 是一种潜在的治疗选择.
- 蛋白质类型对ORS吸收在结节切开术患者的影响还不清楚.
研究的目的:
- 为了研究蛋白质类型或水解是否会影响患者的异骨性ORS的吸收.
- 在ORS中比较乳清蛋白分离物,乳酪酸盐和乳清蛋白水解剂的疗效.
主要方法:
- 这是一项随机的,双盲的,3x3交叉研究,涉及14名骨髓切除术患者.
- 用不同的蛋白质来源 (乳清蛋白分离物,乳酪酸盐,乳清蛋白水解物) 开发了三种异体ORS.
- 患者在4周的时间内每天摄入500毫升,洗间隔;测量了结节管输出量,尿液,血液和其他参数.
主要成果:
- 在干预期间,乳房切除术输出没有显著变化.
- 乳清蛋白分离物ORS在吸收标记上显著改善,包括减少便能量和电解质损失.
- 血阿尔多斯特的改善,估计的淋巴细胞过率 (eGFR) 和乳清蛋白分离物的CO2水平也得到了改善.
结论:
- 使用乳清蛋白分离物,乳酪酸盐或乳清蛋白水解剂的异性ORS并没有改变乳清静脉产量,但安全且耐受良好.
- 乳清蛋白分离物ORS通过改善吸收代理来证明了潜在的益处.
- 推个性化ORS配方和进一步研究,以优化大肠静脉瘤患者的吸收和营养状况.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
106
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
106
Enteral Nutrition I: Orogastric and Nasogastric Feeding
245
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
245
Drugs for Treatment of Diarrhea-Predominant IBS
159
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159
Drugs for Treatment of Constipation-Predominant IBS
157
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157


